Similar articles

• Prulifloxacin ECG study.

  Rosignoli MT, Dionisio P. Rosignoli MT, et al. Clin Drug Investig. 2010;30(4):275-7. doi: 10.2165/11311700-000000000-00000. Clin Drug Investig. 2010. PMID: 20429098 No abstract available.
• Effects of prulifloxacin on cardiac repolarization in healthy subjects: a randomized, crossover, double-blind versus placebo, moxifloxacin-controlled study.

  Rosignoli MT, Di Loreto G, Dionisio P. Rosignoli MT, et al. Clin Drug Investig. 2010;30(1):5-14. doi: 10.2165/11319400-000000000-00000. Clin Drug Investig. 2010. PMID: 19995094 Clinical Trial.
• Prulifloxacin as a trigger of myasthenia gravis.

  Rossi M, Lusini G, Biasella A, Mazzocchio R. Rossi M, et al. J Neurol Sci. 2009 May 15;280(1-2):109-10. doi: 10.1016/j.jns.2009.01.019. Epub 2009 Feb 20. J Neurol Sci. 2009. PMID: 19232642
• Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis.

  Blasi F, Aliberti S, Tarsia P, Santus P, Centanni S, Allegra L. Blasi F, et al. Int J Chron Obstruct Pulmon Dis. 2007;2(1):27-31. doi: 10.2147/copd.2007.2.1.27. Int J Chron Obstruct Pulmon Dis. 2007. PMID: 18044063 Free PMC article. Review.
• Prulifloxacin: a new antibacterial fluoroquinolone.

  Prats G, Rossi V, Salvatori E, Mirelis B. Prats G, et al. Expert Rev Anti Infect Ther. 2006 Feb;4(1):27-41. doi: 10.1586/14787210.4.1.27. Expert Rev Anti Infect Ther. 2006. PMID: 16441207 Review.